Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer.
- DOI
- 10.1016/j.adro.2017.07.009
- Published
- 2017-07-31
- Container
- Adv Radiat Oncol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.adro.2017.07.009,
title = {Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer.},
author = {Vyfhuis MAL and Bhooshan N and Burrows WM and Turner M and Suntharalingam M and Donahue J and Nichols EM and Feliciano J and Bentzen SM and Badiyan S and Carr SR and Friedberg J and Simone CB and Edelman MJ and Feigenberg SJ and Mohindra P.},
year = {2017},
journal = {Adv Radiat Oncol},
doi = {10.1016/j.adro.2017.07.009},
url = {https://doi.org/10.1016/j.adro.2017.07.009}
}RIS
TY - JOUR TI - Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer. AU - Vyfhuis MAL AU - Bhooshan N AU - Burrows WM AU - Turner M AU - Suntharalingam M AU - Donahue J AU - Nichols EM AU - Feliciano J AU - Bentzen SM AU - Badiyan S AU - Carr SR AU - Friedberg J AU - Simone CB AU - Edelman MJ AU - Feigenberg SJ AU - Mohindra P. PY - 2017 JO - Adv Radiat Oncol DO - 10.1016/j.adro.2017.07.009 UR - https://doi.org/10.1016/j.adro.2017.07.009 ER -
APA
MAL, V., N, B., WM, B., M, T., M, S., J, D., EM, N., J, F., SM, B., S, B., SR, C., J, F., CB, S., MJ, E., SJ, F., & P., M. (2017). Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer.. Adv Radiat Oncol. https://doi.org/10.1016/j.adro.2017.07.009
Source records
- europe-pmc · retrieved 2026-09-27T05:47:20.164Z
- doaj · retrieved 2026-09-27T05:47:20.174Z